Review paper

Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?

Volume: 33, Issue: 3, Pages: 309 - 315
Published: Jun 1, 2020
Abstract
Purpose of review Migraine is the second leading cause of years lived with disability after back pain. Poor tolerability, contraindications, drug–drug interactions and efficacy limited to a subpopulation make new approaches necessary for the acute and preventive treatment of migraine. The study of the calcitonin-gene-related peptide (CGRP) pathway over the last decades is a good example of translational medicine leading to directed therapies for...
Paper Details
Title
Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?
Published Date
Jun 1, 2020
Volume
33
Issue
3
Pages
309 - 315
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.